Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
25% Off Benzinga's Most Powerful Trading Tools
Traders Win More with Benzinga's Exclusive News and Squawk
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
VolitionRX
(AMEX:VNRX)
Intraday
$0.5941
-0.0259
[-4.18%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.5941
-0.0259
[-4.18%]
At close: Apr 17
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for VolitionRX Stock (AMEX:VNRX)
VolitionRX Stock (AMEX: VNRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, March 27, 2024
Cantor Fitzgerald Reiterates Overweight on VolitionRX, Maintains $2.5 Price Target
Benzinga Newsdesk
-
Mar 27, 2024, 9:55AM
EF Hutton Maintains Buy on VolitionRX, Maintains $4.5 Price Target
Benzinga Newsdesk
-
Mar 27, 2024, 9:43AM
Monday, March 25, 2024
VolitionRX Q4 EPS $(0.11), Inline, Sales $243.97K Miss $450.00K Estimate
Happy Mohamed
-
Mar 25, 2024, 4:28PM
VolitionRx Cash And Cash Equivalents As Of December 31, 2023, Totaled ~$20.7M
Benzinga Newsdesk
-
Mar 25, 2024, 4:11PM
Earnings Scheduled For March 25, 2024
Benzinga Insights
-
Mar 25, 2024, 5:33AM
Friday, March 22, 2024
Earnings Outlook For VolitionRX
Benzinga Insights
-
Mar 22, 2024, 10:01AM
Wednesday, March 20, 2024
Volition And Fujifilm Vet Systems Launch Nu.Q Vet Cancer Test In Japan
Benzinga Newsdesk
-
Mar 20, 2024, 8:43AM
Thursday, January 04, 2024
Volition Issues Business Review 2023, Outlining Its Key Highlights From The Past Year
Benzinga Newsdesk
-
Jan 4, 2024, 8:05AM
Wednesday, January 03, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Jan 3, 2024, 8:05AM
Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 3, 2024, 7:59AM
Tuesday, January 02, 2024
EF Hutton Reiterates Buy on VolitionRX, Maintains $4.5 Price Target
Benzinga Newsdesk
-
Jan 2, 2024, 1:34PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jan 2, 2024, 12:31PM
Reported Earlier, VolitionRX Says On Dec 29, Received $13M In Milestone Payments From Heska, Post License And Supply Deal Entered Into On March 28, 2022
Benzinga Newsdesk
-
Jan 2, 2024, 11:43AM
Tuesday, December 05, 2023
VolitionRx Secures ~$5.5M In Belgium Regional Government Financing From Wallonie Entreprendre
Benzinga Newsdesk
-
Dec 5, 2023, 8:05AM
Monday, November 27, 2023
IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying
Lisa Levin
-
Nov 27, 2023, 6:26AM
Tuesday, November 21, 2023
EF Hutton Reiterates Buy on VolitionRX, Maintains $4.5 Price Target
Benzinga Newsdesk
-
Nov 21, 2023, 2:14PM
Monday, November 20, 2023
Ondas Holdings And 2 Other Stocks Under $1 Insiders Are Buying
Lisa Levin
-
Nov 20, 2023, 8:45AM
Thursday, November 16, 2023
Cantor Fitzgerald Maintains Overweight on VolitionRX, Raises Price Target to $2.5
Benzinga Newsdesk
-
Nov 16, 2023, 9:31AM
Tuesday, November 14, 2023
VolitionRx Cash And Cash Equivalents Of $10.8M As Of Sept. 30
Benzinga Newsdesk
-
Nov 14, 2023, 4:20PM
Earnings Scheduled For November 14, 2023
Benzinga Insights
-
Nov 14, 2023, 8:23AM
Monday, November 13, 2023
Earnings Preview: VolitionRX
Benzinga Insights
-
Nov 13, 2023, 12:02PM
Monday, October 30, 2023
EF Hutton Initiates Coverage On VolitionRX with Buy Rating, Announces Price Target of $4.5
Benzinga Newsdesk
-
Oct 30, 2023, 10:58AM
Friday, October 13, 2023
Volition Publishes Key Opinion Leader Roundtable Report On NETs In Sepsis
Benzinga Newsdesk
-
Oct 13, 2023, 8:10AM
Friday, October 06, 2023
Top 4 Health Care Stocks That Are Preparing To Pump This Quarter
Lisa Levin
-
Oct 6, 2023, 8:26AM
Friday, September 22, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Sep 22, 2023, 5:31PM
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Sep 22, 2023, 2:22PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Sep 22, 2023, 1:31PM
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 19, 2023, 12:50PM
Thursday, September 07, 2023
ReWalk Robotics And 3 Other Stocks Under $2 Insiders Are Buying
Lisa Levin
-
Sep 7, 2023, 9:05AM
Tuesday, September 05, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Sep 5, 2023, 5:31PM
Tuesday, August 29, 2023
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
Lisa Levin
-
Aug 29, 2023, 9:21AM
Thursday, August 17, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Aug 17, 2023, 5:32PM
Wednesday, August 16, 2023
Cantor Fitzgerald Maintains Overweight on VolitionRX, Lowers Price Target to $2
Benzinga Newsdesk
-
Aug 16, 2023, 8:00AM
Monday, August 14, 2023
VolitionRX Q2 EPS $(0.14) Beats $(0.15) Estimate, Sales $216.31K Miss $270.00K Estimate
Benzinga Newsdesk
-
Aug 14, 2023, 5:19PM
Earnings Scheduled For August 14, 2023
Benzinga Insights
-
Aug 14, 2023, 6:45AM
Wednesday, August 09, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Aug 9, 2023, 12:27PM
Thursday, June 01, 2023
Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Jun 1, 2023, 12:58PM
VolitionRx Limited Announces Pricing Of $16.5M Public Offering At $1.27/Share
Benzinga Newsdesk
-
Jun 1, 2023, 9:22AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Jun 1, 2023, 9:07AM
Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jun 1, 2023, 7:55AM
EF Hutton Assumes VolitionRX at Buy, Announces Price Target of $6
Benzinga Newsdesk
-
Jun 1, 2023, 4:50AM
Wednesday, May 31, 2023
VolitionRx Announces Proposed Underwritten Public Offering Of Common Stock; Size Not Disclosed
Benzinga Newsdesk
-
May 31, 2023, 4:03PM
Wednesday, May 10, 2023
Recap: VolitionRX Q1 Earnings
Benzinga Insights
-
May 10, 2023, 5:32PM
VolitionRX Cash And Cash Equivalents As Of Mar. 31 $10M
Benzinga Newsdesk
-
May 10, 2023, 4:23PM
Earnings Scheduled For May 10, 2023
Benzinga Insights
-
May 10, 2023, 9:12AM
Tuesday, May 09, 2023
VolitionRX's Earnings Outlook
Benzinga Insights
-
May 9, 2023, 2:02PM
Tuesday, May 02, 2023
Watching Humacyte, VolitionRX; Hearing Banyan Hills Newsletter Buys Stock
Benzinga Newsdesk
-
May 2, 2023, 12:35PM
Thursday, March 16, 2023
EF Hutton Reiterates Buy on VolitionRX, Maintains $6 Price Target
Benzinga Newsdesk
-
Mar 16, 2023, 11:23AM
Wednesday, March 15, 2023
VolitionRx Reports FY22 Cash $10.9M
Benzinga Newsdesk
-
Mar 15, 2023, 4:11PM
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Mar 15, 2023, 1:20PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch